Abbott Laboratories 2013 Annual Report Download - page 38

Download and view the complete annual report

Please find page 38 of the 2013 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 76

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76

ABBOTT 2013 ANNUAL REPORT
36
December 31 2013 2012
Assets
Current Assets:
Cash and cash equivalents $ 3,475 $10,802
Investments, primarily bank time deposits and U.S. treasury bills 4,623 4,372
Trade receivables, less allowances of —
2013: $312; 2012: $406 3,986 7,613
Inventories:
Finished products 1,866 2,346
Work in process 349 629
Materials 478 818
Total inventories 2,693 3,793
Deferred income taxes 2,528 2,986
Other prepaid expenses and receivables 1,504 1,757
Current assets held for disposition 438 —
Total Current Assets 19,247 31,323
Investments 119 274
Property and Equipment, at Cost:
Land 502 605
Buildings 2,994 4,259
Equipment 8,506 13,111
Construction in progress 868 954
12,870 18,929
Less: accumulated depreciation and amortization 6,965 10,866
Net Property and Equipment 5,905 8,063
Intangible Assets, net of amortization 5,735 8,588
Goodwill 9,772 15,774
Deferred Income Taxes and Other Assets 2,109 3,213
Non‑current Assets Held for Disposition 66 —
$42,953 $67,235
CONSOLIDATED BALANCE SHEET
(dollars in millions)